In 2020, voters in the U.S. state of Oregon passed Ballot Measure 109, allowing the "manufacture, delivery and administration" of psilocybin, a naturally occurring psychedelic prodrug. While psilocybin remains illegal nationally, the passage of the law made Oregon the first U.S. state to legalize the drug. Per the law, psilocybin must be used for "personal development" and grown and administered in licensed environments. The ballot measure puts in place a two-year period for the government to determine regulations around the law's implementation, such as what credentials will be needed for someone to administer the drug.
| Attributes | Values |
|---|
| rdfs:label
| - 2020 Oregon Ballot Measure 109 (en)
- Référendum de 2020 sur la légalisation de la Psilocybine en Oregon (fr)
|
| rdfs:comment
| - Un référendum sur la légalisation de la Psilocybine a lieu le 3 novembre 2020 en Oregon. La population est amenée à se prononcer sur une initiative populaire, dite Mesure 109, visant à légaliser la Psilocybine en autorisant l'institut de santé de l’État (Oregon Health Authority, OHA) à accorder des licences pour la vente de produits à base de champignon contenant de la Psilocybine aux individus de plus de 21 ans. Il s'agit de la toute première initiative populaire sur cette question aux États-Unis. Le projet est approuvé à une large majorité. (fr)
- In 2020, voters in the U.S. state of Oregon passed Ballot Measure 109, allowing the "manufacture, delivery and administration" of psilocybin, a naturally occurring psychedelic prodrug. While psilocybin remains illegal nationally, the passage of the law made Oregon the first U.S. state to legalize the drug. Per the law, psilocybin must be used for "personal development" and grown and administered in licensed environments. The ballot measure puts in place a two-year period for the government to determine regulations around the law's implementation, such as what credentials will be needed for someone to administer the drug. (en)
|
| name
| |
| dcterms:subject
| |
| Wikipage page ID
| |
| Wikipage revision ID
| |
| Link from a Wikipage to another Wikipage
| |
| Link from a Wikipage to an external page
| |
| sameAs
| |
| dbp:wikiPageUsesTemplate
| |
| yes
| |
| country
| |
| no
| |
| notes
| - Source: Associated Press (en)
|
| title
| - Legalize Psilocybin: (en)
- Allows manufacture, delivery, administration of psilocybin at supervised, licensed facilities; imposes two-year development period (en)
|
| Total
| |
| has abstract
| - In 2020, voters in the U.S. state of Oregon passed Ballot Measure 109, allowing the "manufacture, delivery and administration" of psilocybin, a naturally occurring psychedelic prodrug. While psilocybin remains illegal nationally, the passage of the law made Oregon the first U.S. state to legalize the drug. Per the law, psilocybin must be used for "personal development" and grown and administered in licensed environments. The ballot measure puts in place a two-year period for the government to determine regulations around the law's implementation, such as what credentials will be needed for someone to administer the drug. The chief petitioners behind the bill were Sheri and Thomas Eckert, both therapists who had been working for years to legalize psilocybin because of its potential benefit for people struggling with conditions including depression, anxiety, and addiction. To get the initiative (called the Psilocybin Service Initiative, or Initiative Petition #34) on the November 2020 ballot, 112,020 signatures of support from Oregonians had to be collected. On November 3, 2020, Ballot Measure 109 was passed with support from 1.27 million Oregonians, or 55.75% of the vote (according to unofficial results from the Oregon Secretary of State in the days following the election). (en)
- Un référendum sur la légalisation de la Psilocybine a lieu le 3 novembre 2020 en Oregon. La population est amenée à se prononcer sur une initiative populaire, dite Mesure 109, visant à légaliser la Psilocybine en autorisant l'institut de santé de l’État (Oregon Health Authority, OHA) à accorder des licences pour la vente de produits à base de champignon contenant de la Psilocybine aux individus de plus de 21 ans. Il s'agit de la toute première initiative populaire sur cette question aux États-Unis. Le projet est approuvé à une large majorité. (fr)
|
| prov:wasDerivedFrom
| |
| page length (characters) of wiki page
| |
| foaf:isPrimaryTopicOf
| |
| is Link from a Wikipage to another Wikipage
of | |
| is Wikipage redirect
of | |
| is foaf:primaryTopic
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)